Finland· FI-REL-REL1377
Diprinovet Prolongatum Vet
A sulfonamidien ja trimetopriimin yhdistelmävalmisteet product containing baquiloprim + sulfadimidine, registered in Finland by Schering-Plough A/S.
Checked against Fimea (Finland) on
Informational only — not a medical device.
The record
At a glance
Fimea (Finland)- Active substance
- Baquiloprim + Sulfadimidine
- Manufacturer
- Schering-Plough A/S
- Country
- Finland (FI)
- ATC code
- QJ01EW30
- ATC class
- Sulfonamidien ja trimetopriimin yhdistelmävalmisteet
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under QJ01EW30
Sulfonamidien ja trimetopriimin yhdistelmävalmisteet, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab7d64a1-79f5-4c7c-80fe-ebdd54ebd2e9 GET /v1/drugs/ab7d64a1-79f5-4c7c-80fe-ebdd54ebd2e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "boli",
"route": null,
"ddd_unit": null,
"strength": null,
"atc_label": "Sulfonamidien ja trimetopriimin yhdistelmävalmisteet",
"ma_number": "11702",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL1377",
"authorised_at": "1996-11-06"
}See everything about baquiloprim + sulfadimidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.